E-LIB Suche - Ergebnisse für: Ak, Muzeyyen Aslaner

1

MAINTENANCE LOW-DOSE CORTICOSTEROID THERAPY IN PATIENTS WIT..:

Yesiralioğlu, Birsen Sahip ; Ayağ, Hatice ; Ak, Müzeyyen Aslaner.
Hematology, Transfusion and Cell Therapy. 46 (2024) - p. 5 , 2024

Link: https://doi.org/10.1016/..

2

A CASE OF RECURRENT DIFFUSE LARGE B CELL NONHODGKIN LYMPHOM..:

Ak, Müzeyyen Aslaner ; Yesiralioğlu, Birsen Sahip ; Ayağ, Hatice..
Hematology, Transfusion and Cell Therapy. 46 (2024) - p. 17-18 , 2024

Link: https://doi.org/10.1016/..

3

ACUTE MYELOID LEUKEMIA DIAGNOSED WITH CUTANEOUS INVOLVEMENT..:

AYAG, HATICE ; Ak, Müzeyyen Aslaner ; Yesiralioğlu, Birsen Sahip..
Hematology, Transfusion and Cell Therapy. 46 (2024) - p. 14-15 , 2024

Link: https://doi.org/10.1016/..

4

POSTER: MDS-225 The Long-Term Efficacy of Erythropoiesis-St..:

Ak, Müzeyyen Aslaner ; Gedük, Ayfer ; Açar, İbrahim Halil...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S181 , 2023

Link: https://doi.org/10.1016/..

5

THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA ..:

Ak, Müzeyyen Aslaner ; Sahip, Birsen ; Geduk, Ayfer...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S39 , 2023

Link: https://doi.org/10.1016/..

6

The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa ..:

Ak, Muzeyyen Aslaner ; Sahip, Birsen ; Geduk, Ayfer...
Indian Journal of Hematology and Blood Transfusion. 38 (2021) 2 - p. 299-308 , 2021

Link: https://doi.org/10.1007/..

7

MDS-225 The Long-Term Efficacy of Erythropoiesis-Stimulatin..:

Aslaner Ak, Müzeyyen ; Gedük, Ayfer ; Açar, İbrahim Halil...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S358 , 2023

Link: https://doi.org/10.1016/..

8

Experience of Daratumumab in Relapsed/Refractory Multiple M..:

Tekinalp, Atakan ; Gedük, Ayfer ; Akdeniz, Aydan...
Turkish Journal of Hematology. 40 (2023) 4 - p. 242-250 , 2023

Link: https://doi.org/10.4274/..

9

Long-Term Efficacy of Erythropoiesis-Stimulating Agents in ..:

Aslaner Ak, Müzeyyen ; Gedük, Ayfer ; Acar, İbrahim Halil...
Turkish Journal of Hematology. 40 (2023) 2 - p. 92-100 , 2023

Link: https://doi.org/10.4274/..

10

IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC..:

Açar, İbrahim Halil ; Izmir Güner, Sebnem ; Aslaner Ak, Muzeyyen...
Mediterranean Journal of Hematology and Infectious Diseases. 14 (2022) 1 - p. e2022074 , 2022

Link: https://doi.org/10.4084/..

11

VITAMIN B 12 DEFICIENCY MIMICKING THROMBOTIC MICROANGIOPATH..:

Aslaner Ak, Müzeyyen ; Yiğit, Selime ; Süren, Gizem.
Hematology, Transfusion and Cell Therapy. 44 (2022) - p. S36 , 2022

Link: https://doi.org/10.1016/..

12

Tyrosine kinase inhibitor nilotinib induced palmoplantar er..:

Aslaner Ak, Muzeyyen ; Ertop Doğan, Pelin ; Sahip, Birsen
Journal of Oncology Pharmacy Practice. 28 (2022) 3 - p. 763-765 , 2022

Link: https://doi.org/10.1177/..

13

Experience of Daratumumab in Relapsed/Refractory Multiple M..:

Atakan Tekinalp ; Ayfer Gedük ; Aydan Akdeniz...
https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-20586. , 2023

Link: https://doi.org/10.4274/..

14

Long-Term Efficacy of Erythropoiesis-Stimulating Agents in ..:

Müzeyyen Aslaner Ak ; Ayfer Gedük ; İbrahim Halil Açar...
https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-47715. , 2023

Link: https://doi.org/10.4274/..

15

THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA ..:

Müzeyyen Aslaner Ak ; Birsen Sahip ; Ayfer Geduk...
http://www.sciencedirect.com/science/article/pii/S2531137923002432. , 2023

Link: https://doi.org/10.1016/..